EANS-Adhoc: LifeWatch receives Swiss Equity Award for successful corporate development Swiss Equity Conference presents first prize to LifeWatch

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

Company Information

16.09.2009

Neuhausen am Rheinfall / Switzerland, September 16, 2009 - At the
Swiss Equity Conference in Zurich, LifeWatch AG (SIX Swiss Exchange:
LIFE), the leading provider of wireless cardiac monitoring services
in the U.S., was awarded the first prize for excellent corporate
development in the most difficult economic times.

There are only a few Swiss small and mid-cap companies which have
delivered an excellent performance even in the most difficult times
like these. According to the jury of the Swiss Equity Award,
LifeWatch is one such company. The jury presented LifeWatch AG´s
Management with the first prize at this year´s Swiss Equity
conference. LifeWatch received the award based on its share price
development from September 1, 2008, (10.00 CHF) leading up to August
31, 2009, (17.95 CHF) and votes cast by analysts and professional
investors. All companies listed on the Swiss Market Index SMI,
excluding Swiss large caps, were eligible for the award.

About LifeWatch AG LifeWatch AG, headquartered in Neuhausen am
Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is
the leading healthcare technology and solution company, specializing
in advanced telehealth systems and wireless cardiac monitoring
services. LifeWatch services treat high-risk and chronically ill
patients, health conscious consumers and wellness programs. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent
company of LifeWatch Services Inc., a leading US-based cardiac
monitoring service provider, and manufacturer of telecardiology
products. www.lifewatch.com

Sign-up for customized e-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results
of operations and financial position, business strategy and plans and
objectives for future operations, are forward-looking statements.
The words "believe," "may," "will," "estimate," "continue,"
"anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has
based these forward looking statements largely on current
expectations and projections about future events and financial
trends that it believes may affect the financial condition,
results of operations, business strategy, short term and long term
business operations and objectives, and financial needs. These
forward-looking statements are subject to a number of risks,
uncertainties and assumptions. In light of these risks,
uncertainties and assumptions, the forward-looking events and
circumstances described may not occur and actual results could
differ materially and adversely from those anticipated or implied in
the forward-looking statements. All forward-looking statements
are based only on data available to LifeWatch AG at the time of the
issue of this press release. LifeWatch AG does not undertake any
obligation to update any forward- looking statements contained
in this press release as a result of new information, future
events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS
OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED
STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF
SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN
THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY
SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED
STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS
SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE
UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE
UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO
BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS
THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS
APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER
AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.

-----------------------

Press Release

September 16, 2009

Ende der Mitteilung euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

For further information from LifeWatch please contact:

Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG

Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | E-mail kobibe@lifewatch.com

Sensus Investor & Public Relations GmbH, Zürich:

Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / free trade